Clinical Trial Update: A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years [Phase 4]

View source ↗

Summary

This is a Phase 4 trial update. It reports the 2-year follow-up results for preterm infants given iodide supplementation to address transient hypothyroxinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Hypothyroxinemia of Prematurity

Drugs mentioned

• Iodide supplementation (iodide)

Snippet

Sponsor: University of Oxford | Conditions: Transient Hypothyroxinemia | Phase 4 | Status: COMPLETED